Indication
Efficacy of Treatment
3 clinical trials
4 products
Clinical trial
A Phase I/II, Open-Label, Non-Randomized, Multicentre, Dose-Escalation Clinical Trial With Control Group to Evaluate the Safety, Feasibility and Preliminary Efficacy of PRAME TCR Modified T Cells, MDG1011, in Subjects With High Risk Myeloid and Lymphoid NeoplasmsStatus: Terminated, Estimated PCD: 2022-06-28
Product
MDG1011Clinical trial
Evaluation of Brain Connectivity Function in Predicting Therapeutic Effects in Patients With Refractory Constipation: a Multicenter, Prospective, Cohort StudyStatus: Recruiting, Estimated PCD: 2025-09-01
Product
fluoxetineClinical trial
Efficacy and Safety of Continuous Versus Intermittent Linezolid Infusion in Critically Ill Patients With Septic ShockStatus: Recruiting, Estimated PCD: 2023-12-02
Product
Linezolid